Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07644442
Clinical Trial
Study on [14C]HMPL-453(FGFR Inhibitor) in Healthy Chinese Adult Male Subjects
Completed
Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the absorption, metabolism and excretion in healthy Chinese male subjects after a single oral dose of \[14C\]HMPL-453
Trial Details
NCT Number
NCT07644442
Lead Sponsor
Hutchmed
Conditions
Mass Balance Study
Enrollment
6 participants
Start Date
2025-02-26
Primary Completion
2025-03-14
(estimated)
Study Completion
2025-03-14
(estimated)
Updated on ClinicalTrials.gov
2026-06-12